Yajima Y, Fukuda I, Otsuki M, Suzuki H, Mori K, Goto Y
Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Gastroenterol Jpn. 1989 Jun;24(3):262-9. doi: 10.1007/BF02774323.
We have found that endotoxemia detected by conventional LCT (limulus colorimetric test) in patients with liver diseases could not be detected by endotoxin-specific LCT at all, and proposed that this beta-glucan like activity (BGLA) should be termed as non-septic endotoxemia, distinguishing it from septic endotoxemia seen in gram-negative sepsis. In this study, we investigated non-septic endotoxemia through the clinical course of 8 cirrhotic patients. Non-septic endotoxemia appeared at the onset of DIC but tended to decline in level in the late terminal stage. This phenomenon cannot be consistent with the "spillover" theory which explains the mechanism of endotoxemia without sepsis in liver disease. We think it is an urgent problem to elucidate the nature of BGLA in liver disease, without recourse to the "spillover" theory.
我们发现,在肝病患者中,通过传统鲎试剂比色法(LCT)检测到的内毒素血症,根本无法通过内毒素特异性LCT检测出来。我们提出,这种类β-葡聚糖活性(BGLA)应被称为非脓毒症性内毒素血症,以区别于革兰氏阴性菌败血症中所见的脓毒症性内毒素血症。在本研究中,我们通过8例肝硬化患者的临床病程来研究非脓毒症性内毒素血症。非脓毒症性内毒素血症在弥散性血管内凝血(DIC)发作时出现,但在终末期后期水平趋于下降。这种现象与解释肝病中非脓毒症性内毒素血症机制的“溢出”理论不一致。我们认为,在不依赖“溢出”理论的情况下阐明肝病中BGLA的性质是一个紧迫的问题。